|
COMMD10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.101000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.659800E-03 |
| Normal-vs-Stage2 |
9.289800E-01 |
| Normal-vs-Stage3 |
7.283000E-03 |
| Normal-vs-Stage4 |
2.05859999999891E-05 |
| Stage1-vs-Stage2 |
3.988100E-02 |
| Stage1-vs-Stage3 |
8.558600E-01 |
| Stage1-vs-Stage4 |
2.990500E-02 |
| Stage2-vs-Stage3 |
4.456400E-02 |
| Stage2-vs-Stage4 |
1.463750E-03 |
| Stage3-vs-Stage4 |
8.377800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.216200E-03 |
| Normal-vs-AfricanAmerican |
8.964900E-03 |
| Normal-vs-Asian |
2.958200E-04 |
| Caucasian-vs-AfricanAmerican |
6.230400E-01 |
| Caucasian-vs-Asian |
2.495800E-01 |
| AfricanAmerican-vs-Asian |
8.436600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.916300E-03 |
| Normal-vs-Female |
5.961900E-03 |
| Male-vs-Female |
8.428200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.818600E-03 |
| Normal-vs-Age(41-60Yrs) |
6.018500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.134390E-02 |
| Normal-vs-Age(81-100Yrs) |
8.320000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.923200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.778600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.566200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.577600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.884200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.277600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.613800E-01 |
| Classical-VS-Follicular |
1.356260E-02 |
| Classical-VS-Other |
7.673800E-01 |
| Classical-VS-Normal |
2.801000E-03 |
| Tall-VS-Follicular |
1.413570E-02 |
| Tall-VS-Other |
9.270400E-01 |
| Tall-VS-Normal |
3.399300E-03 |
| Follicular-VS-Other |
2.988200E-01 |
| Follicular-VS-Normal |
5.712000E-01 |
| Other-VS-Normal |
9.976400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.264900E-03 |
| Normal-vs-N1 |
9.53769999999521E-05 |
| N0-vs-N1 |
5.207800E-02 |
|
|
